Evidence map›Paper›PMID 39528344›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2024

[Cognitive function groups in older people and risk factors].

Jessica Camacho-Ruíz, Antonio V, Mario Enrique Rendón-Macías, Mariela Bernabe-García, Emmanuel González-Bautista, Leticia Manuel-Apolinar, Lourdes Basurto-Acevedo, Oscar Orihuela-Rodríguez, Juana M Ruiz-Batalla, Braulio Rojas-Rubio and 3 more

Registry-linked trialAbstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07284316 (Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07284316 phase2 / phase3active not recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance: A Randomized Clinical Trial

TypeinterventionalSponsorInstituto Mexicano del Seguro SocialRan2025 to 2027Enrolled100ConditionsCognitive Decline, Subjective Cognitive Impairment, Insulin ResistanceArmsTurmeric extract, Control: Placebo. 500mg gelatin in capsules 2 times a day
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Incidence of the progression and remission of cognitive decline in older adults].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jessica Camacho-RuízInstituto Mexicano del Seguro Social, Órgano de Operación Administrativa Desconcentrada CDMX Sur, Unidad de Medicina Familiar No. 28, Admisión Continua. Ciudad de México, México.ORCID 0000-0003-4207-3251
Antonio VUniversidad Nacional Autónoma de México, Facultad de Medicina, División de Investigación. Ciudad de México, México.ORCID 0000-0003-2003-9351
Mario Enrique Rendón-MacíasUniversidad Panamericana, Escuela de Medicina, Facultad de Ciencias de la Salud. Ciudad de México, México.ORCID 0000-0001-7310-6656
Mariela Bernabe-GarcíaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Pediatría "Dr. Silvestre Frenk Freund", Unidad de Investigaciones Médicas en Nutrición. Ciudad de México, México.ORCID 0000-0001-9970-2077
Emmanuel González-BautistaUniversité de Toulouse, Gérontopole of Toulouse, Institute of Aging, Toulouse University Hospital (CHU Toulouse), Maintain Aging Research Team, CERPOP. Toulouse, Haute-Garonne, France.ORCID 0000-0001-9844-3034
Leticia Manuel-ApolinarInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Investigación Médica de Enfermedades Endocrinas. Ciudad de México, México.ORCID 0000-0001-8175-4215
Lourdes Basurto-AcevedoInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Investigación Médica de Enfermedades Endocrinas. Ciudad de México, México.ORCID 0000-0002-2991-0433
Oscar Orihuela-RodríguezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Servicio de Cardiología. Ciudad de México, México.ORCID 0000-0001-7148-5533
Juana M Ruiz-BatallaInstituto Mexicano del Seguro Social, Órgano de Operación Administrativa Desconcentrada CDMX Sur, Unidad de Medicina Familiar No. 1, Coordinación de Educación e Investigación en Salud. Ciudad de México, México.ORCID 0000-0003-0793-9910
Braulio Rojas-RubioInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Coordinación de Investigación en Salud, Unidad de Investigación Epidemiológica y de Servicios en Salud. Ciudad de México, México.ORCID 0000-0001-5716-6798
Roberto A Olivares-SantosInstituto Mexicano del Seguro Social, Órgano de Operación Administrativa Desconcentrada CDMX Sur, Unidad de Medicina Familiar No. 10, Coordinación de Educación e Investigación en Salud. Ciudad de México, México.ORCID 0009-0004-1384-8008
Carlos Paredes-ManjarrezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Servicio de Imagenología. Ciudad de México, México.ORCID 0000-0002-3319-7634
Rosalinda Sánchez-ArenasInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Coordinación de Investigación en Salud, Unidad de Investigación Epidemiológica y de Servicios en Salud. Ciudad de México, México.ORCID 0000-0003-2043-9363

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Risk stratification for cognitive impairment in communities originated from autopsies in cognitively healthy individuals. The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) incorporates subjective and objective cognitive function (CF) measures to explore neurocognitive disorders (NCD). It can be applied in communities to explore the factors that may influence positively or negatively. Objective: To obtain the relationship between groups of CF classified using the DSM-5 categories, and sociodemographic factors, habits, comorbidities and motor function in older people living in the community. Material and methods: Cross-sectional study with a probabilistic sample (n = 347). The variables were sociodemographic, habits, comorbidities, and cognitive motor function. The participants were grouped considering subjective and objective CF, plus age, sex, and educational level, and defined according to NCD. Results: 28.5% did not present cognitive disorder, 43.9% had mild disorder < 70 years (mildNCD < 70y), 19% with 70 years or more (mildNCD ≥ 70y), and with major disorder 8.6%. The associated factors for mildNCD < 70y were marital status (MS), physical activity (PA), diabetes mellitus, and frailty; for mildNCD > 70y: MS, occupation, living alone, and heart disease; for majorNCD: PA and grip strength. In the multivariate analysis it was observed greater likelihood in the mildNCD groups than in the non-NCD and majorNCD groups. Conclusions: 4 important groups were identified in a community. The mildNCD was mainly explained by sociodemographic factors, lifestyle, clinical conditions, and motor functionality.

Indexed as

Cognitive DysfunctionAgedAged, 80 and overCross-Sectional StudiesDiagnostic and Statistical Manual of Mental DisordersFemaleHumansMaleMexicoMiddle AgedRisk FactorsCluster Analysis, Neurocognitive DisordersCognitive FunctionRisk Factors

Identifiers

PMID39528344
PMCPMC12208709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.